MindMed Plans MDMA-LSD Trial To Study ‘Bad Trip’ Reduction

Green Market News reports…Mind Medicine (MindMed) Inc. (NEO: MMED)(OTCQB: MMEDF)announced that it is working with the University Hospital Basel’s Liechti Lab on a combination … Read More… The post MindMed Plans MDMA-LSD Trial To Study ‘Bad Trip’ Reduction first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : MindMed Plans MDMA-LSD Trial To Study ‘Bad Trip’ Reduction
reposted by Cannabis News World